Manulife (Manufacturers Life Insurance)
NVCR icon

Manulife (Manufacturers Life Insurance)’s NovoCure NVCR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$432K Sell
39,598
-1,705
-4% -$21.3K ﹤0.01% 2223
2025
Q4 		$534K Sell
41,303
-1,654
-4% -$21.2K ﹤0.01% 2150
2025
Q3 		$555K Sell
42,957
-2,697
-6% -$36K ﹤0.01% 2164
2025
Q2 		$813K Sell
45,654
-46,916
-51% -$818K ﹤0.01% 1920
2025
Q1 		$1.65M Sell
92,570
-60,032
-39% -$1.36M ﹤0.01% 1570
2024
Q4 		$4.55M Sell
152,602
-49,425
-24% -$1.05M ﹤0.01% 1249
2024
Q3 		$3.16M Buy
202,027
+14,255
+8% +$258K ﹤0.01% 1391
2024
Q2 		$3.22M Buy
187,772
+37,951
+25% +$667K ﹤0.01% 1330
2024
Q1 		$2.34M Buy
149,821
+29,034
+24% +$427K ﹤0.01% 1466
2023
Q4 		$1.8M Buy
120,787
+23,609
+24% +$316K ﹤0.01% 1504
2023
Q3 		$1.57M Buy
97,178
+6,776
+7% +$195K ﹤0.01% 1518
2023
Q2 		$3.75M Buy
90,402
+2,807
+3% +$174K ﹤0.01% 1213
2023
Q1 		$5.27M Buy
87,595
+13,806
+19% +$1.1M ﹤0.01% 1053
2022
Q4 		$5.28M Sell
73,789
-2,974
-4% -$224K ﹤0.01% 1047
2022
Q3 		$5.91M Buy
76,763
+5,361
+8% +$418K ﹤0.01% 970
2022
Q2 		$5.17M Buy
71,402
+15,753
+28% +$1.19M ﹤0.01% 1086
2022
Q1 		$4.68M Buy
+55,649
New +$4.1M ﹤0.01% 1220
2021
Q3 		– Sell
-15,014
Closed -$3.33M – 3197
2021
Q2 		$3.33M Buy
15,014
+44
+0.3% +$8.56K ﹤0.01% 1432
2021
Q1 		$1.98M Sell
14,970
-129
-0.9% -$20.4K ﹤0.01% 1543
2020
Q4 		$2.61M Buy
15,099
+485
+3% +$66.4K ﹤0.01% 1438
2020
Q3 		$1.63M Hold
14,614
– – ﹤0.01% 1484
2020
Q2 		$1.15M Sell
14,614
-52,631
-78% -$3.46M ﹤0.01% 1559
2020
Q1 		$4.53M Buy
67,245
+3,012
+5% +$238K 0.01% 1056
2019
Q4 		$5.8M Sell
64,233
-991
-2% -$80K 0.01% 1123
2019
Q3 		$4.79M Buy
65,224
+11,201
+21% +$896K 0.01% 1170
2019
Q2 		$3.42M Buy
54,023
+8,018
+17% +$406K ﹤0.01% 1279
2019
Q1 		$2.22M Sell
46,005
-18,047
-28% -$869K ﹤0.01% 1394
2018
Q4 		$2.15M Sell
64,052
-46,234
-42% -$1.69M ﹤0.01% 1367
2018
Q3 		$5.78M Buy
110,286
+56,995
+107% +$2.27M 0.01% 1186
2018
Q2 		$1.67M Buy
53,291
+8,880
+20% +$247K ﹤0.01% 1570
2018
Q1 		$968K Sell
44,411
-709
-2% -$15.2K ﹤0.01% 1863
2017
Q4 		$911K Buy
45,120
+140
+0.3% +$2.7K ﹤0.01% 1911
2017
Q3 		$892K Sell
44,980
-1,136
-2% -$22.3K ﹤0.01% 1872
2017
Q2 		$797K Buy
46,116
+3,266
+8% +$42.2K ﹤0.01% 1943
2017
Q1 		$347K Buy
42,850
+6,131
+17% +$44.3K ﹤0.01% 2441
2016
Q4 		$289K Buy
36,719
+86
+0.2% +$692 ﹤0.01% 2509
2016
Q3 		$313K Buy
36,633
+1,389
+4% +$12.7K ﹤0.01% 2427
2016
Q2 		$412K Buy
35,244
+29,997
+572% +$376K ﹤0.01% 2163
2016
Q1 		$70K Buy
+5,247
New +$75.3K ﹤0.01% 3198

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVCR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its NovoCure (NVCR) stake by 4.1% in Q1 2026, selling an estimated $21.3K and leaving 39,598 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Manulife (Manufacturers Life Insurance) first reported a position in NVCR in Q1 2016 and has held it in 39 quarters since. The position peaked at $5.91M in Q3 2022. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 39,598 shares of NovoCure worth $432K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,705 NovoCure shares in Q1 2026, an estimated $21.3K.
  • NovoCure made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2223 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in NovoCure in Q1 2016 and has held it in 39 quarters since.
  • Manulife (Manufacturers Life Insurance)'s NovoCure position peaked at $5.91M in Q3 2022.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.